Your Health, We Care
Release date: 2026-03-26 17:03:03 Article From: Lucius Laos Recommended: 85
As a drug used for treating certain tumors, tazemetostat may cause varying degrees of side effects in some patients due to individual differences, while exerting its antitumor effects.
Urinary System: Bladder pain, blood in urine or cloudy urine, difficulty urinating/burning sensation/pain, frequent urge to urinate, pain in the lower back or side.
Hematologic System: Bleeding gums, nosebleeds, bleeding from wounds that does not stop, unusual bleeding or bruising, pale skin.
Respiratory System: Chest pain or tightness, cough, coughing up blood, difficulty breathing or swallowing, sore throat, nasal congestion or runny nose, sneezing, ear fullness.
Musculoskeletal System: Body aches or pain, muscle or bone pain.
Skin and Mucous Membranes: Redness/itching/pain/swelling/tenderness/warmth of the skin.
Nervous System: Dizziness, headache.
Reproductive System: Increased menstrual flow or vaginal bleeding.
Systemic Symptoms: Fever or chills, unusual tiredness or weakness, loss of voice.
Confusion, rapid heartbeat, dizziness or fainting, painful blisters on the torso, rapid and shallow breathing.
General discomfort, hoarseness, ulcers, sores, or white patches on the lips or inside the mouth, swollen glands, weight loss, yellowing of the skin and eyes.
Constipation, decreased appetite, diarrhea, hair loss or thinning hair, nausea or vomiting, rash, abdominal pain.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：3502025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：5512024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：3362025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：3522025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：3272025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：3932025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：3262025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：3012025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
